www.fdanews.com/articles/153292-eisai-gets-orphan-drug-status-for-lenvatinib

Eisai Gets Orphan Drug Status for Lenvatinib

February 15, 2013

Eisai has received orpan-drug designation from the FDA for Lenvatinib, its investigational drug for thyroid cancer.
MarketWatch